Medical university of vienna, General hospital of Vienna
Welcome,         Profile    Billing    Logout  
 11 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Trauner, Michael
COMBAT_T2_NASH, NCT04639414: Combined Active Treatment in Type 2 Diabetes With NASH

Recruiting
4
192
Europe
Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector, Jardiance(R), Ozempic(R), Empagliflozin 10mg oral tablet and placebo pen injector matching semaglutide, Jardiance(R), Placebo matching empagliflozin and placebo pen injector matching semaglutide, Control / Placebo
The Deutsche Diabetes Forschungsgesellschaft e.V., Boehringer Ingelheim, German Center for Diabetes Research, Federal Ministry of Health, Germany, Ministry of Innovation, Science and Research in North Rhine-Westphalia, Novo Nordisk A/S
Type 2 Diabetes, Non-alcoholic Steatohepatitis (NASH), Non-alcoholic Fatty Liver Disease (NAFLD)
01/25
12/25
NCT03872921: norUrsodeoxycholic Acid vs Placebo in PSC

Recruiting
3
300
Europe
norUrsodeoxycholic Acid, NUC
Dr. Falk Pharma GmbH
Primary Sclerosing Cholangitis
04/21
12/23
NCT04594694 / 2018-002575-17: Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC

Active, not recruiting
2
72
Europe, RoW
Obeticholic acid, Bezafibrate 200 MG, OCA Placebo, Bezafibrate 200 mg Placebo, Bezafibrate 400 MG, Bezafibrate 400 mg Placebo, OCA, Bezafibrate
Intercept Pharmaceuticals
Primary Biliary Cholangitis
10/25
12/25
NCT05083390 / 2018-003443-31: Norursodeoxycholic Acid vs. Placebo in NASH

Recruiting
2
363
Europe
norUrsodeoxycholic acid, norucholic acid, norUDCA, NCA
Dr. Falk Pharma GmbH, Dr. Falk Pharma GmbH,
Nonalcoholic Steatohepatitis
01/25
04/25
Weber, Ulrike
PLATON, NCT04484636: - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)

Recruiting
N/A
400
Europe
FoundationOne®CDx and FoundationOne®Liquid
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Roche Pharma AG
Hepatocellular Cancer, Cholangiocarcinoma, Gallbladder Cancer, Pancreatic Cancer, Oesophageal Cancer, Stomach Cancer
06/24
07/24
Bernardi, Martin H
NCT05077124: Safe and Timely Antithrombotic Removal (STAR) Registry

Recruiting
N/A
500
Europe
CytoSorb
CytoSorbents, Inc
Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical, Blood Loss, Postoperative
09/25
09/25
Schmid, Werner
No trials found
Mora, Bruno
No trials found
Zapletal, Bernhard
No trials found

Download Options